or
Remember me
Back
This novel combination therapy is positioned to compete with Pfizer's flagship antiviral therapeutic But of course, this kind of news does not move the share price. That takes revenue, cash flow >>> Profits! Show me the $$$$
A daily snapshot of everything from market open to close.